Cell and tissue engineering for liver disease

Sangeeta N. Bhatia, Gregory H. Underhill, Kenneth S. Zaret, Ira J. Fox

Research output: Contribution to journalReview article

Abstract

Despite the tremendous hurdles presented by the complexity of the liver's structure and function, advances in liver physiology, stem cell biology and reprogramming, and the engineering of tissues and devices are accelerating the development of cell-based therapies for treating liver disease and liver failure. This State of the Art Review discusses both the near- and long-term prospects for such cell-based therapies and the unique challenges for clinical translation.

Original languageEnglish (US)
Article number245sr2
JournalScience Translational Medicine
Volume6
Issue number245
DOIs
StatePublished - Jul 16 2014

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this